XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Mar. 29, 2022
Stockholders’ Equity [Line Items]          
Total unrecognized compensation expense $ 257,519 $ 257,519      
Weighted average period   2 years 4 months 24 days      
Aggregate intrinsic value of stock options, outstanding 492,169 $ 492,169 $ 20,430    
Aggregate intrinsic value of stock options, exercisable $ 306,498 $ 306,498 19,867    
Common stock exercise price per share (in Dollars per share) $ 2.78 $ 2.78      
Common stock purchase shares (in Shares)   4,000      
Exercise price (in Dollars per share)   $ 2.68      
Aggregate fair value of options granted   $ 72,240 $ 90,380    
Stock options exercised (in Shares) 14,830 14,830      
Average exercise price (in Dollars per share) $ 2.68        
Weighted average share price (in Dollars per share) $ 4.12        
Exercise stock options $ 39,772        
Common stock outstanding         $ 1,750,000
Common stock, treasury shares (in Shares) 641,963 641,963   641,963  
2011 Long-Term Incentive Plan [Member]          
Stockholders’ Equity [Line Items]          
Number of stock options were exercised (in Shares)   16,976      
2016 Long-Term Incentive Plan [Member]          
Stockholders’ Equity [Line Items]          
Number of stock options were exercised (in Shares)   1,300,000      
Percentage of incentive stock option   100.00%      
Number of shares available for future issuance (in Shares) 607,685 607,685      
Equity Option [Member]          
Stockholders’ Equity [Line Items]          
Number of stock options were exercised (in Shares) 0        
Exercise stock options $ 39,772        
Aggregate intrinsic value $ 21,341        
Board of Directors [Member]          
Stockholders’ Equity [Line Items]          
Purchase an aggregate of common stock (in Shares)   24,000      
Exercise price (in Dollars per share)   $ 2.78